My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1102

    1.

    Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia.

    Brodsky RA, Sensenbrenner LL, Smith BD, Dorr D, Seaman PJ, Lee SM, Karp JE, Brodsky I, Jones RJ.

    Ann Intern Med. 2001 Oct 2;135(7):477-83.PMID: 11578150 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation.

    Brodsky RA, Sensenbrenner LL, Jones RJ.

    Blood. 1996 Jan 15;87(2):491-4.PMID: 8555470 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    High-dose cyclophosphamide as salvage therapy for severe aplastic anemia.

    Brodsky RA, Chen AR, Brodsky I, Jones RJ.

    Exp Hematol. 2004 May;32(5):435-40.PMID: 15145211 [PubMed - indexed for MEDLINE]Related articles

    4.

    High-dose cyclophosphamide to treat severe aplastic anemia.

    [No authors listed]

    Ann Intern Med. 2001 Oct 2;135(7):S-1. No abstract available. PMID: 11596572 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease.

    Brodsky RA, Petri M, Smith BD, Seifter EJ, Spivak JL, Styler M, Dang CV, Brodsky I, Jones RJ.

    Ann Intern Med. 1998 Dec 15;129(12):1031-5.PMID: 9867758 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.

    Doney K, Leisenring W, Storb R, Appelbaum FR.

    Ann Intern Med. 1997 Jan 15;126(2):107-15.PMID: 9005744 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO).

    Bacigalupo A, Bruno B, Saracco P, Di Bona E, Locasciulli A, Locatelli F, Gabbas A, Dufour C, Arcese W, Testi G, Broccia G, Carotenuto M, Coser P, Barbui T, Leoni P, Ferster A.

    Blood. 2000 Mar 15;95(6):1931-4.PMID: 10706857 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Treatment of adults with severe aplastic anemia: primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation.

    Crump M, Larratt LM, Maki E, Curtis JE, Minden MD, Meharchand JM, Lipton JH, Messner HA.

    Am J Med. 1992 Jun;92(6):596-602.PMID: 1605140 [PubMed - indexed for MEDLINE]Related articles

    9.

    Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide.

    Savage WJ, DeRusso PA, Resar LM, Chen AR, Higman MA, Loeb DM, Jones RJ, Brodsky RA.

    Pediatr Blood Cancer. 2007 Dec;49(7):947-51.PMID: 17252566 [PubMed - indexed for MEDLINE]Related articles

    10.

    Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.

    Rosenfeld S, Follmann D, Nunez O, Young NS.

    JAMA. 2003 Mar 5;289(9):1130-5.PMID: 12622583 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.

    Marsh J, Schrezenmeier H, Marin P, Ilhan O, Ljungman P, McCann S, Socie G, Tichelli A, Passweg J, Hows J, Raghavachar A, Locasciulli A, Bacigalupo A.

    Blood. 1999 Apr 1;93(7):2191-5.PMID: 10090926 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial.

    Tisdale JF, Dunn DE, Geller N, Plante M, Nunez O, Dunbar CE, Barrett AJ, Walsh TJ, Rosenfeld SJ, Young NS.

    Lancet. 2000 Nov 4;356(9241):1554-9.PMID: 11075769 [PubMed - indexed for MEDLINE]Related articles

    13.

    Predictive factors for cure after immunosuppressive therapy of aplastic anemia.

    Viollier R, Tichelli A.

    Acta Haematol. 2000;103(1):55-62.PMID: 10705160 [PubMed - indexed for MEDLINE]Related articles

    14.

    Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: multicenter trial.

    Ahn MJ, Choi JH, Lee YY, Choi IY, Kim IS, Yoon SS, Park SY, Kim BK, Suh C, Son HJ, Jung CW, Lee JH, Sung JM, Im SA, Oh D, Jung SY, Yoon HJ, Cho KS, Lee JA, Yuh YJ, Kim SR, Ki M.

    Int J Hematol. 2003 Aug;78(2):133-8.PMID: 12953807 [PubMed - indexed for MEDLINE]Related articles

    15.

    The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program.

    Elias AD, Ibrahim J, Richardson P, Avigan D, Joyce R, Reich E, McCauley M, Wheeler C, Frei E 3rd.

    Biol Blood Marrow Transplant. 2002;8(4):198-205.PMID: 12017145 [PubMed - indexed for MEDLINE]Related articles

    16.

    Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.

    Führer M, Burdach S, Ebell W, Gadner H, Haas R, Harbott J, Janka-Schaub G, Klingebiel T, Kremens B, Niemeyer C, Rampf U, Reiter A, Ritter J, Schulz A, Walther U, Zeidler C, Bender-Götze C.

    Klin Padiatr. 1998 Jul-Aug;210(4):173-9.PMID: 9743949 [PubMed - indexed for MEDLINE]Related articles

    17.

    Improved survival in severe acquired aplastic anemia of childhood.

    Fouladi M, Herman R, Rolland-Grinton M, Jones-Wallace D, Blanchette V, Calderwood S, Doyle J, Halperin D, Leaker M, Saunders EF, Zipursky A, Freedman MH.

    Bone Marrow Transplant. 2000 Dec;26(11):1149-56.PMID: 11149724 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.

    Kim HJ, Park CY, Park YH, Kim YJ, Kim DW, Min WS, Kim CC.

    Bone Marrow Transplant. 2003 Jan;31(2):79-86.PMID: 12621487 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Experience in the use of allogeneic bone marrow transplantation in severe forms of aplastic anemia at the Byelorussian hematological center]

    Uss AL, Zmachinskiĭ VA, Milanovich NF, Skriagin AE, Batan ZE, Dziuba EV, Mitskevich PB, Smirnova LA.

    Ter Arkh. 1999;71(7):69-72. Russian. PMID: 10481871 [PubMed - indexed for MEDLINE]Related articles

    20.

    Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience.

    Gómez-Almaguer D, Vela-Ojeda J, Jaime-Pérez JC, Gutiérrez-Aguirre CH, Cantú-Rodríguez OG, Sobrevilla-Calvo P, Rivas-Vera S, Gómez-Rangel JD, Ruiz-Argüelles GJ.

    Am J Hematol. 2006 Mar;81(3):157-61.PMID: 16493614 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity